Vraylar has been approved by the U.S. Food and Drug Administration to treat two forms of mental illness among adults, schizophrenia and bipolar disorder. Vraylar has been approved by the U.S. Food and Drug Administration to treat two forms of mental illness among adults, schizophrenia and bipolar disorder.